Thinking of joining a study?

Register your interest

NCT06926816 | RECRUITING | Genetic Testing


Universal Genetic Testing for Cancer Risk Reduction
Sponsor:

NYU Langone Health

Brief Summary:

The purpose of this research study is to see if offering genetic testing for cancer-related genes is feasible and acceptable for patients presenting for gynecology clinic visits, instead of needing to see specialized providers or needing to meet specific criteria. The primary aim to assess the proportion of patients who undergo genetic testing, and the proportion of patients with pathogenic variants.

Condition or disease

Genetic Testing

Intervention/treatment

Natera® Empower™ hereditary cancer panel test

Specialist Referral

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 600 participants
Masking : NONE
Primary Purpose : SCREENING
Official Title : Universal Genetic Testing for Cancer Risk Reduction
Actual Study Start Date : 2025-03-04
Estimated Primary Completion Date : 2026-12-31
Estimated Study Completion Date : 2027-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 25 Years to 39 Years
Sexes Eligible for Study: FEMALE
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria
  • 1. Female patients between ages of 25-39 years at the time of visit
  • 2. Receive gynecologic care at an affiliated NYU Langone Health (NYULH) site listed in this protocol.
Exclusion Criteria
  • 1. Personal history of ovarian, fallopian tube, primary peritoneal, or uterine cancers
  • 2. Previously undergone germline testing for ovarian cancer risk variants (prior commercial saliva-based kits, such as 23andMe, are acceptable)
  • 3. History of bilateral salpingo-oophorectomy
  • 4. Visit related to pregnancy or immediately postpartum (within 2 weeks)

Universal Genetic Testing for Cancer Risk Reduction

Location Details

NCT06926816


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, New York

NYU Langone Health

New York, New York, United States, 10016

Loading...